Novo Nordisk nach Split WKN: A3EU6F ISIN: DK0062498333 Kürzel: NOV Forum: Aktien User: Coronaprofiteur
40,83
EUR
-0,31 % -0,13
17:53:34 Uhr,
Baader Bank
Kommentare 55.195
McLovin09,
22. Jul 9:03 Uhr
1
𝗣𝗿𝗲𝘀𝗶𝗱𝗲𝗻𝘁 𝗧𝗿𝘂𝗺𝗽 - 𝟬𝟯:𝟱𝟰 𝗣𝗠 𝗣𝗦𝗧 𝟬𝟳.𝟮𝟭.𝟮𝟲 - 𝗧𝗿𝘂𝘁𝗵 𝗦𝗼𝗰𝗶𝗮𝗹 𝗣𝗼𝘀𝘁 "Effective August 1st, 2026, all Generic Drugs being brought into the United States will continue to have a TARIFF of ZERO PERCENT for a two year period of time, after which the TARIFF will be raised to 100% for a one year period of time, and 200% thereafter. This is done in order to RESHORE Generic Pharmaceutical Production into America, with a penalty to those Companies that decide not to build Plant and Equipment within the stated period of time given to them. The objective of this Policy is to protect the people of the United States. The Policy on Patented, Branded, or Innovative Drugs, which has been so successful, will remain as is. Pharmaceutical Facilities are being built, at a level never seen before, all over the United States of America. Thank you for your attention to this matter! President DONALD J. TRUMP
Betrifft Novo überhaupt nicht.
csl1234,
22. Jul 9:33 Uhr
1
Eines zeigt die Meldung von Trump aber: die Zeit arbeitet gegen ihn. Die 200% Zoll wären nicht mal mehr in seiner Amtszeit.
csl1234,
22. Jul 11:44 Uhr
2
Novo Nordisk seeks Wegovy pill approval in South Africa *** https://medwatch.com/News/Pharma___Biotech/article19489538.ece
McLovin09,
22. Jul 12:10 Uhr
1
Bin echt gespannt was am 05.08. so alles veröffentlicht wird. Irgendwie muss man ja den ganzen Bedarf decken können.
In China soll man ja Interesse an API Lieferanten haben, könnte mir vorstellen das es dazu neuigkeiten geben könnte.
PiZZaMaN2,
22. Jul 12:46 Uhr
0
https://www.reuters.com/legal/litigation/many-us-patients-opt-obesity-drug-injections-defying-some-expectations-2026-07-22/
Papadopoulos,
22. Jul 8:47 Uhr
0
𝗣𝗿𝗲𝘀𝗶𝗱𝗲𝗻𝘁 𝗧𝗿𝘂𝗺𝗽 - 𝟬𝟯:𝟱𝟰 𝗣𝗠 𝗣𝗦𝗧 𝟬𝟳.𝟮𝟭.𝟮𝟲 - 𝗧𝗿𝘂𝘁𝗵 𝗦𝗼𝗰𝗶𝗮𝗹 𝗣𝗼𝘀𝘁
"Effective August 1st, 2026, all Generic Drugs being brought into the United States will continue to have a TARIFF of ZERO PERCENT for a two year period of time, after which the TARIFF will be raised to 100% for a one year period of time, and 200% thereafter. This is done in order to RESHORE Generic Pharmaceutical Production into America, with a penalty to those Companies that decide not to build Plant and Equipment within the stated period of time given to them. The objective of this Policy is to protect the people of the United States. The Policy on Patented, Branded, or Innovative Drugs, which has been so successful, will remain as is. Pharmaceutical Facilities are being built, at a level never seen before, all over the United States of America. Thank you for your attention to this matter! President DONALD J. TRUMP
TradeRpro,
21. Jul 23:17 Uhr
0
Es tut in der Seele gut, keine 3x,xx mehr zu sehen. Oft hat man eine gute These aber der Markt lässt lange bluten. Ich hoffe ich nehme hier gute Gewinne mit, trotz meinem "hohen" EK.
McLovin09,
21. Jul 21:42 Uhr
1
$VKTX $NVO $LLY $KLRA $PTGX - Bachem announced a new major agreement to supply a large volumes of peptides to an undisclosed partner who has committed to pre payments and long term production‼
➡Even more significant is that they also announced plans to invest $615M USD for a new Swiss based greenfield plant with commercial production starting in 2030. This plant is targeted for high volume mfg.
➡Clearly new greenfield peptide production (probably for the oral peptides?) is needed and large investment is being made in cGMP facilities in Europe.
➡ IMO it is likely that this new production will employ mostly tag based peptide manufacturing which dramatically reduces costs vs SPPS
➡$BANB.SW was up 10% on this news
bachem.com/articles/news/…
McLovin09,
21. Jul 20:44 Uhr
1
RSI im Stundenchart jetzt nahe der 30. Könnte also bald wieder drehen.
csl1234,
21. Jul 20:27 Uhr
0
Aber vielleicht gibt Trump jetzt aktiv die Richtung bei Lilly vor: Alternative Fakten ...
McLovin09,
21. Jul 19:23 Uhr
2
Agios Pharmaceuticals ($AGIO ) has discontinued development of tebapivat for sickle cell disease after a mid stage trial failed to show enough benefit to justify further development.
Following the news, analysts noted that the decision strengthens Novo's position in sickle cell disease. RBC Capital Markets said the setback makes Novo Nordisk's etavopivat more likely to remain best in class.
Mehr zu diesem Wert
|
|
Thema | ||
|---|---|---|---|
| 1 | Novo Nordisk nach Split | ||
| 2 | Novo Nordisk |
Meistdiskutiert
|
|
Thema | ||
|---|---|---|---|
| 1 | PLUG POWER Hauptdiskussion | -3,66 % | |
| 2 | DEUTSCHE TELEKOM Hauptdiskussion | -3,00 % | |
| 3 | Germany 40 Hauptdiskussion | ±0,00 % | |
| 4 | Germany 40 / DAX Prognose | ±0,00 % | |
| 5 | Ecograf - ein Stern am Graphithimmel | -4,41 % | |
| 6 | Battalion | +8,77 % | |
| 7 | Beyond Meat Hauptdiskussion | -3,30 % | |
| 8 | RHEINMETALL Hauptdiskussion | -0,30 % | |
| 9 | WIENERBERGER Hauptdiskussion | -2,69 % | |
| 10 | für alle, die es ehrlich meinen beim Traden. | Alle Diskussionen |
Aktien
|
|
Thema | ||
|---|---|---|---|
| 1 | PLUG POWER Hauptdiskussion | -4,14 % | |
| 2 | DEUTSCHE TELEKOM Hauptdiskussion | -2,87 % | |
| 3 | Ecograf - ein Stern am Graphithimmel | -4,41 % | |
| 4 | Battalion | +8,77 % | |
| 5 | Beyond Meat Hauptdiskussion | -3,19 % | |
| 6 | RHEINMETALL Hauptdiskussion | -0,30 % | |
| 7 | Keel Infrastructure Corporation Hauptdiskussion | -10,44 % | |
| 8 | WIENERBERGER Hauptdiskussion | -2,69 % | |
| 9 | ATOS Hauptdiskussion | -3,49 % | |
| 10 | Hims & Hers Health Registered (A) Hauptdiskussion | +0,77 % | Alle Diskussionen |